Back to Industries & Applications
Overview
The world's geriatric population continues growing dramatically, prompting a related increase in the prevalence of chronic ailments and infectious disease communicability. These interdependent dynamics have prompted the need to explore more efficient, personalized and precise diagnostic approaches. Miniaturization and advancing medical technologies are presenting new opportunities to help tackle these issues.
Consistent with ongoing, human-centered industry shifts toward remote patient monitoring and wearable medical devices, certain point-of-care diagnostic testing can now take place in either clinical settings or an individual’s home. In vitro diagnostics use a complex array of assays and reagents to identify medical conditions by analyzing a patient’s bodily fluids and/or tissue samples. All related instruments and software algorithms must work together seamlessly to make this possible—so precision design and manufacturing of complex in vitro diagnostic equipment is absolutely imperative.
Keeping up with an ever-evolving profusion of safety, quality and regulatory guidelines in this space can be challenging for today’s manufacturers. Supply chain uncertainties, costing concerns, reimbursement models, documentation hurdles and risk mitigation challenges can often further complicate or even entirely disrupt business continuity—measurably impacting product realization initiatives and impeding time to market.
This is why today’s leading organizations often turn to specialized, globally integrated providers who can offer knowledgeable support and state-of-the-art production efficiencies. Phillips-Medisize, a Molex company, empowers customers with 60+ years of proven product realization proficiency in the medical technology sector and across highly regulated industries. Substantial one-stop expertise with precision injection molding, high-performance medical interconnects, complex custom cable assemblies, fiber optics and more helps tomorrow’s in vitro innovations take shape today—for optimized patient care that actively improves lives around the world.
By the Numbers
USD 113 Billion
In Vitro Market Size
1.1 Billion
Wearable Devices Sold
20%
Medtech Spend Growth
Featured Resources
Featured Videos
In this insightful and informative webchat Mike Deppe, Vice President & General Manager at Molex discusses relevant trends and opportunities driving new solutions for Medical Wearables applications. Watch this lively, interactive, 5-minute dialogue regarding Molex capabilities for the Medical Wearables industry.
Designing Medical Wearables for Real-Life